Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. 1998

J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
Departments of Pathology, Medicine, and the Myeloma and Transplantation Research Center, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Multicolor spectral karyotyping (SKY) was performed on bone marrow samples from 50 patients with multiple myeloma (MM) in anticipation of discovering new previously unidentified translocations. All samples showed complex karyotypes with chromosome aberrations which, in most cases, were not fully characterized by G-banding. Patients of special interest were those who showed add(14)(q32), add(8)(q24) and those whose G-banding karyotypes showed poor chromosome morphology. Three new recurring chromosome translocations not previously reported in MM were identified. Two of the translocations involve recurring aberrations at band 14q32.3, the site of the IgH locus, with different exchange partners. The most frequently recurring rearrangement was a subtle translocation at 14q32.3 designated as a t(14;16)(q32;q22 approximately 23), which was identified in six patients. A second and larger translocation at 14q32, identified in two patients, was designated as a t(9;14)(p13;q32), previously associated with Waldenstrom's macroglobulinemia and lymphoplasmacytoid lymphoma. A third translocation, identified in two patients, involved a whole-arm t(6;8)(p10;q10) translocation. The SKY technique was able to refine the designations of over 156 aberrations not fully characterized by G-banding in this study and resolved additional chromosome aberrations in every patient studied except two. The t(14;16)(q32;q22 approximately 23) identified by SKY in this study suggests this may be a frequent translocation in MM associated with complex karyotypes and disease progression. Therefore, the SKY technique provides a useful adjunct to routine G-banding and fluorescence in situ hybridization studies in the cytogenetic analysis of MM.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D002883 Chromosomes, Human, Pair 14 A specific pair of GROUP D CHROMOSOMES of the human chromosome classification. Chromosome 14
D002885 Chromosomes, Human, Pair 16 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 16
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014178 Translocation, Genetic A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome. Chromosomal Translocation,Translocation, Chromosomal,Chromosomal Translocations,Genetic Translocation,Genetic Translocations,Translocations, Chromosomal,Translocations, Genetic

Related Publications

J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
September 1998, Blood,
J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
January 2005, Methods in molecular medicine,
J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
March 2001, Leukemia,
J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
August 1999, Sangre,
J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
January 2003, Cytogenetic and genome research,
J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
July 1996, Science (New York, N.Y.),
J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
July 1999, Cancer genetics and cytogenetics,
J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
February 2002, Genes, chromosomes & cancer,
J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
June 2001, Genes, chromosomes & cancer,
J R Sawyer, and J L Lukacs, and N Munshi, and K R Desikan, and S Singhal, and J Mehta, and D Siegel, and J Shaughnessy, and B Barlogie
January 2003, Oncology reports,
Copied contents to your clipboard!